{
  "hash": "c6f754619c12fbd24bd3dfc1055c606a",
  "result": {
    "engine": "knitr",
    "markdown": "# National Drug Codes {#sec-ndcapi}\n\n\n\n## Links\n\n   * [`openFDA` NDC API: Home](https://open.fda.gov/apis/drug/ndc/)\n   * [`openFDA` NDC API: How to use the API](https://open.fda.gov/apis/drug/ndc/how-to-use-the-endpoint/)\n   * [FDA: Drug Approvals and Databases](https://www.fda.gov/drugs/development-approval-process-drugs/drug-approvals-and-databases)\n   * [NIH: `RxNorm`](https://lhncbc.nlm.nih.gov/RxNav/APIs/api-RxNorm.getNDCProperties.html)\n\n## Catalog\n\n::: {.cell}\n\n```{.r .cell-code}\nx <- request(\"https://api.fda.gov/drug/ndc.json\") |>\n  req_perform() |>\n  resp_body_string()\n\n# fload(x, query = \"\")\n\nx\n```\n\n::: {.cell-output .cell-output-stdout}\n\n```\n[1] \"{\\n  \\\"meta\\\": {\\n    \\\"disclaimer\\\": \\\"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.\\\",\\n    \\\"terms\\\": \\\"https://open.fda.gov/terms/\\\",\\n    \\\"license\\\": \\\"https://open.fda.gov/license/\\\",\\n    \\\"last_updated\\\": \\\"2025-02-26\\\",\\n    \\\"results\\\": {\\n      \\\"skip\\\": 0,\\n      \\\"limit\\\": 1,\\n      \\\"total\\\": 129913\\n    }\\n  },\\n  \\\"results\\\": [\\n    {\\n      \\\"product_ndc\\\": \\\"78206-188\\\",\\n      \\\"generic_name\\\": \\\"Desloratadine\\\",\\n      \\\"labeler_name\\\": \\\"Organon LLC\\\",\\n      \\\"brand_name\\\": \\\"Clarinex\\\",\\n      \\\"active_ingredients\\\": [\\n        {\\n          \\\"name\\\": \\\"DESLORATADINE\\\",\\n          \\\"strength\\\": \\\"5 mg/1\\\"\\n        }\\n      ],\\n      \\\"finished\\\": true,\\n      \\\"packaging\\\": [\\n        {\\n          \\\"package_ndc\\\": \\\"78206-188-01\\\",\\n          \\\"description\\\": \\\"100 TABLET, FILM COATED in 1 BOTTLE (78206-188-01)\\\",\\n          \\\"marketing_start_date\\\": \\\"20220823\\\",\\n          \\\"sample\\\": false\\n        }\\n      ],\\n      \\\"listing_expiration_date\\\": \\\"20251231\\\",\\n      \\\"openfda\\\": {\\n        \\\"manufacturer_name\\\": [\\n          \\\"Organon LLC\\\"\\n        ],\\n        \\\"rxcui\\\": [\\n          \\\"349420\\\",\\n          \\\"352086\\\"\\n        ],\\n        \\\"spl_set_id\\\": [\\n          \\\"c671342e-69a2-4ca5-abc2-8166ed4240d4\\\"\\n        ],\\n        \\\"is_original_packager\\\": [\\n          true\\n        ],\\n        \\\"upc\\\": [\\n          \\\"0378206188014\\\",\\n          \\\"0378206119018\\\"\\n        ],\\n        \\\"nui\\\": [\\n          \\\"N0000000190\\\",\\n          \\\"N0000175587\\\"\\n        ],\\n        \\\"pharm_class_moa\\\": [\\n          \\\"Histamine H1 Receptor Antagonists [MoA]\\\"\\n        ],\\n        \\\"pharm_class_epc\\\": [\\n          \\\"Histamine-1 Receptor Antagonist [EPC]\\\"\\n        ],\\n        \\\"unii\\\": [\\n          \\\"FVF865388R\\\"\\n        ]\\n      },\\n      \\\"marketing_category\\\": \\\"NDA\\\",\\n      \\\"dosage_form\\\": \\\"TABLET, FILM COATED\\\",\\n      \\\"spl_id\\\": \\\"56d88176-c545-4aed-a9e7-6b1696243c86\\\",\\n      \\\"product_type\\\": \\\"HUMAN PRESCRIPTION DRUG\\\",\\n      \\\"route\\\": [\\n        \\\"ORAL\\\"\\n      ],\\n      \\\"marketing_start_date\\\": \\\"20220823\\\",\\n      \\\"product_id\\\": \\\"78206-188_56d88176-c545-4aed-a9e7-6b1696243c86\\\",\\n      \\\"application_number\\\": \\\"NDA021165\\\",\\n      \\\"brand_name_base\\\": \\\"Clarinex\\\",\\n      \\\"pharm_class\\\": [\\n        \\\"Histamine H1 Receptor Antagonists [MoA]\\\",\\n        \\\"Histamine-1 Receptor Antagonist [EPC]\\\"\\n      ]\\n    }\\n  ]\\n}\"\n```\n\n\n:::\n:::\n\n::: {.cell}\n\n```{.r .cell-code}\njsonify::pretty_json(x)\n```\n\n::: {.cell-output .cell-output-stdout}\n\n```\n{\n    \"meta\": {\n        \"disclaimer\": \"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.\",\n        \"terms\": \"https://open.fda.gov/terms/\",\n        \"license\": \"https://open.fda.gov/license/\",\n        \"last_updated\": \"2025-02-26\",\n        \"results\": {\n            \"skip\": 0,\n            \"limit\": 1,\n            \"total\": 129913\n        }\n    },\n    \"results\": [\n        {\n            \"product_ndc\": \"78206-188\",\n            \"generic_name\": \"Desloratadine\",\n            \"labeler_name\": \"Organon LLC\",\n            \"brand_name\": \"Clarinex\",\n            \"active_ingredients\": [\n                {\n                    \"name\": \"DESLORATADINE\",\n                    \"strength\": \"5 mg/1\"\n                }\n            ],\n            \"finished\": true,\n            \"packaging\": [\n                {\n                    \"package_ndc\": \"78206-188-01\",\n                    \"description\": \"100 TABLET, FILM COATED in 1 BOTTLE (78206-188-01)\",\n                    \"marketing_start_date\": \"20220823\",\n                    \"sample\": false\n                }\n            ],\n            \"listing_expiration_date\": \"20251231\",\n            \"openfda\": {\n                \"manufacturer_name\": [\n                    \"Organon LLC\"\n                ],\n                \"rxcui\": [\n                    \"349420\",\n                    \"352086\"\n                ],\n                \"spl_set_id\": [\n                    \"c671342e-69a2-4ca5-abc2-8166ed4240d4\"\n                ],\n                \"is_original_packager\": [\n                    true\n                ],\n                \"upc\": [\n                    \"0378206188014\",\n                    \"0378206119018\"\n                ],\n                \"nui\": [\n                    \"N0000000190\",\n                    \"N0000175587\"\n                ],\n                \"pharm_class_moa\": [\n                    \"Histamine H1 Receptor Antagonists [MoA]\"\n                ],\n                \"pharm_class_epc\": [\n                    \"Histamine-1 Receptor Antagonist [EPC]\"\n                ],\n                \"unii\": [\n                    \"FVF865388R\"\n                ]\n            },\n            \"marketing_category\": \"NDA\",\n            \"dosage_form\": \"TABLET, FILM COATED\",\n            \"spl_id\": \"56d88176-c545-4aed-a9e7-6b1696243c86\",\n            \"product_type\": \"HUMAN PRESCRIPTION DRUG\",\n            \"route\": [\n                \"ORAL\"\n            ],\n            \"marketing_start_date\": \"20220823\",\n            \"product_id\": \"78206-188_56d88176-c545-4aed-a9e7-6b1696243c86\",\n            \"application_number\": \"NDA021165\",\n            \"brand_name_base\": \"Clarinex\",\n            \"pharm_class\": [\n                \"Histamine H1 Receptor Antagonists [MoA]\",\n                \"Histamine-1 Receptor Antagonist [EPC]\"\n            ]\n        }\n    ]\n}\n```\n\n\n:::\n:::\n\n",
    "supporting": [
      "api_ndc_files"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {},
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}